Anastrozole
18 NDCs across 10 manufacturers|17 Generic,1 Brand
Anastrozole is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 27, 1995, and the first generic was approved Jun 28, 2010. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $36 million on Anastrozole across 1.7 million claims for 435,000 beneficiaries.
Anastrozole is available as 18 NDCs from 10 manufacturers (17 generic, 1 brand), with NADAC prices from $0.14 to $52.86 per EA — the most expensive product costs about 387× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
18
17G / 1B
Manufacturers
10
competing in market
Price Spread
$0.14 – $52.86
per EA
7d Activity
avg +3.4% WoW · of 18 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
10 manufacturers producing ANASTROZOLE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ARIMIDEX 1 MG TABLET | $52.8616 per EA | — |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1401 per EA | +3.36% |
ANASTROZOLE 1 MG TABLET | $0.1366 per EA | — |
Frequently Asked Questions
What is Anastrozole used to treat?
Anastrozole is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
When did Anastrozole become available as a generic?
FDA approved the first generic Anastrozole (ANDA) on Jun 28, 2010. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Anastrozole?
In 2024, Medicare Part D spent $36 million on Anastrozole across 1.7 million claims for 435,000 beneficiaries.
How many Anastrozole products are on the market?
The Anastrozole drug market contains 18 NDCs from 10 manufacturers — 17 generic and 1 brand product.
What is the price range for Anastrozole?
NADAC reference prices for Anastrozole range from $0.1366 to $52.8616 per EA — the most expensive product costs about 387× the cheapest.
Is generic Anastrozole cheaper than brand?
The average generic NADAC for Anastrozole is $0.1399 per EA, versus $52.8616 for brand-labeled products — brand versions average about 378× the generic price.
Which manufacturers make Anastrozole?
10 manufacturers list Anastrozole in NADAC. Ranked by number of NDCs, the largest are Accord Healthcare Inc. (3), Breckenridge Pharmaceutical Inc. (3), Aurobindo Pharma Limited (2), Chartwell RX LLC (2), BluePoint Laboratories (2).
How has the price of Anastrozole changed recently?
Over the past 7 days, 16 Anastrozole NDCs rose and 0 fell, with a market-wide average change of +3.4%.